Medical-conditions Clinical Testing of Drug NNZ-2591 for Angelman Syndrome Commences in Australia (Phase 2) , and Administrator 2025 September 25
Medical-conditions Health Sector Victims of Record-Breaking Cases of Ransomware Assaults Over the Past Four Years. , and Administrator 2025 September 25
Medical-conditions 5K Run Promotes Organ Donation and Celebrates Stevenson High School Students , and Administrator 2025 September 25
Medical-conditions Agency advisory panel rejects combined MMRV vaccine for kids under 4 years old , and Administrator 2025 September 25
Medical-conditions First Gene Therapy Trial for Batten Disease to be Conducted at Our Medical Center , and Administrator 2025 September 25
Medical-conditions Swift Remedy: Effective Strategies for Immediate Relief from Whistling Breathing , and Administrator 2025 September 25
Medical-conditions Essential Information Regarding Flu Variants , and Administrator 2025 September 25
Medical-conditions Connection Between Asthma and Back Pain: Is There a Possibility? , and Administrator 2025 September 24
Medical-conditions Unveiled Innovation Reveals the Mechanisms of Cancer Cell Telomere Healing through Molecular Processes , and Administrator 2025 September 24
Medical-conditions Relief for Rescue Services: Draft Bill Approved , and Administrator 2025 September 24
Medical-conditions Alzheimer's Association fundraising walk scheduled in Greenfield to take place on Saturday , and Administrator 2025 September 24
Medical-conditions Massive job losses from six pharmaceutical companies could eliminate approximately 39,000 positions. , and Administrator 2025 September 24
Medical-conditions Daily Impact: The Influence of Rising Temperatures and Air Pollution on Your Health Instantaneously , and Administrator 2025 September 24
Medical-conditions Stock performance of CureVac: Signifying a significant shift or the twilight of an era? , and Administrator 2025 September 24
Medical-conditions AI-Driven Revolution in Identifying Potential Medical Treatments , and Administrator 2025 September 24
Medical-conditions Our group strongly opposes the extension of the problematic 340B drug pricing program. , and Administrator 2025 September 24
